Skip to main content
Premium Trial:

Request an Annual Quote

Almac Outfits New $1.6M Mass Spec Lab with Agilent 6530 Q-TOF, 6460 Triple Quad


UK-based CRO Almac said this week it has established a new £1 million ($1.6 million) mass spectrometry laboratory.

According to Jon Cook, the company's head of analytical chemistry, the facility will house seven mass spectrometers, including four new instruments purchased from Agilent.

The new machines include an Agilent 6530 Q-TOF and an Agilent 6460 Triple Quadrupole, both of which have an Agilent 1290 Infinity LC on the front end, Cook told ProteoMonitor. These instruments will be used for accurate mass and quantitation work, the company said.

The other two new Agilent instruments are an Agilent 6224 TOF with a 1290 LC and an Agilent 5975C GC/MS attached to a 7890 GC.

The Scan

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.

Mitochondrial Replacement Therapy Embryos Appear Largely Normal in Single-Cell 'Omics Analyses

Embryos produced with spindle transfer-based mitochondrial replacement had delayed demethylation, but typical aneuploidy and transcriptome features in a PLOS Biology study.

Cancer Patients Report Quality of Life Benefits for Immune Checkpoint Inhibitors

Immune checkpoint inhibitor immunotherapy was linked in JAMA Network Open to enhanced quality of life compared to other treatment types in cancer patients.

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.